Group 1 - The core viewpoint of the news is that Spring Medical has seen a stock price increase of 5.42%, reaching 26.06 CNY per share, with a total market capitalization of 9.996 billion CNY as of the report date [1] - Spring Medical, established on February 12, 1998, specializes in the research, production, and sales of implantable orthopedic medical devices, with its main products including joint prosthetics and spinal implants [1] - The company's revenue composition is primarily from medical device products, accounting for 99.89%, with a minor contribution from other sources at 0.11% [1] Group 2 - Among the top circulating shareholders of Spring Medical, a fund under China Europe Fund, specifically the China Europe Prosperity Selected Mixed A (020876), has entered the top ten shareholders, holding 2.8326 million shares, which is 0.74% of the circulating shares [2] - The China Europe Prosperity Selected Mixed A fund has achieved a year-to-date return of 7.47% and a one-year return of 63.55%, ranking 1811 out of 8836 and 1302 out of 8091 respectively [2] - The fund manager, Zhang Xueming, has been in position for 1 year and 266 days, with the fund's total asset size at 6.741 billion CNY and a best return of 79% during his tenure [3]
春立医疗股价涨5.42%